ITGAX and gastric cancer: Although ITGAX is well-studied in inflammatory conditions, such as neuroinflammation, non-alcoholic steatohepatitis, and dermatitis-like inflammation (Kalluri and Weinberg, 2009; Yan et al., 2022; Ullah et al., 2024), its functional significance in gastric cancer remains poorly understood.